These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2019-003714-14 Modulation of the FOLFIRI-based standard 1st-line therapy with cetuximab, controlled by monitoring the RAS mutation load by liquid biopsy in RAS-mutated mCRC patients Anpassung einer FOLFIRI-Erstli... bad-data
Other 2022-003408-33 PACCELIO - FDG-PET based small volume accelerated immuno chemoradio-therapy in locally advanced NSCLC not-yet-due